Catherine A. Sohn

Director, Maze Therapeutics, Inc.; Director, Altimmune, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.1M

Companies

Latest trade

Jan 7, 2026

Companies

Maze Therapeutics, Inc.Director −$1.1M Altimmune, Inc.Director +$0.0M

Trades

MAZE Sold 26,920 shares at $39.11 $1.1M Jan 7

MAZE Sold 2,493 shares at $38.62 $0.1M Jan 6

ALT Bought 500 shares at $4.24 $0.0M Jan 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.